Why PROCIPIENT® Sets the Standard for the Critical Role of High Purity Solvents in Complex Drug Delivery Systems!

Author(s):

In this interview, Rishi Pimentel of gChem explains how PROCIPIENT®, a cGMP-compliant excipient-grade DMSO, supports advanced therapies with superior purity and sterility, mitigates risks of using industrial-grade solvents, and strengthens regulatory readiness and supply chain security.

Sponsored by gChem

In this interview, Rishi Pimentel of gChem discusses how PROCIPIENT®, a cGMP-compliant excipient-grade DMSO, safeguards parenteral, topical, and advanced therapy formulations by ensuring purity and sterility, meeting evolving regulatory demands, and reducing risks associated with using industrial-grade solvents. He also highlights how gChem’s focus on practical applications, lifecycle management, and supply chain security provides strategic advantages for formulators navigating complex development pipelines.

Learning Objectives:

Understand solvent impact
Evaluate regulatory readiness
Explore practical applications
Learn why supply chain transparency and security are gChem’s strategic differentiators

Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.

Subscribe Now!